A multi-centre, open label, randomised, parallel-group, superiority Trial to compare the efficacy of URsodeoxycholic acid with RIFampicin in the management of women with severe early onset Intrahepatic Cholestasis of pregnancy: the TURRIFIC randomised trial

BACKGROUND: Severe early onset (less than 34 weeks gestation) intrahepatic cholestasis of pregnancy (ICP) affects 0.1% of pregnant women in Australia and is associated with a 3-fold increased risk of stillbirth, fetal hypoxia and compromise, spontaneous preterm birth, as well as increased frequencie...

Descripción completa

Detalles Bibliográficos
Autores principales: Hague, William M., Callaway, Leonie, Chambers, Jennifer, Chappell, Lucy, Coat, Suzette, de Haan-Jebbink, Jiska, Dekker, Marloes, Dixon, Peter, Dodd, Jodie, Fuller, Maria, Gordijn, Sanne, Graham, Dorothy, Heikinheimo, Oskari, Hennessy, Annemarie, Kaaja, Risto, Khong, Teck Yee, Lampio, Laura, Louise, Jennie, Makris, Angela, Markus, Corey, Marschall, Hanns-Ulrich, Middleton, Philippa, Mol, Ben W., Morris, Jonathan, Newnham, John P., Ovadia, Caroline, Peek, Michael, Shand, Antonia, Stark, Michael, Thornton, Jim, Timonen, Susanna, Walker, Susan, Warrilow, David, Williamson, Catherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802989/
https://www.ncbi.nlm.nih.gov/pubmed/33435904
http://dx.doi.org/10.1186/s12884-020-03481-y

Ejemplares similares

Ejemplares similares